The RIVAL Trial showed radial access has advantages to femoral access.
Feature | Radial Access | Dave Fornell

April 8, 2011 — In the largest randomized trial to compare radial access and femoral access for coronary angiography and intervention, researchers found radial access reduced rates of vascular complications, according to research presented this week at the American College of Cardiology (ACC) Scientific Session in New Orleans.

Home April 08, 2011
Home
Feature

April 8, 2011 – In the largest randomized, multicenter trial to compare drug-eluting stents (DES) and bare-metal stents (BMS) placed in saphenous vein graft lesions, researchers found that DES led to a lower combined rate of death, heart attack and repeat revascularization. The research findings were presented this week at the American College of Cardiology’s 60th Annual Scientific Session.

Home April 08, 2011
Home
Feature

April 8, 2011 – A Canadian research team found that the radial artery outperformed the saphenous vein as the best conduit for coronary artery bypass graft (CABG) surgery. The radial artery also led to reduced rates of functional or complete graft occlusion, according to research presented this week at the American College of Cardiology’s 60th Annual Scientific Session.

Home April 08, 2011
Home
Feature

The transcatheter MitraClip mitral valve repair system continues to compare favorably with conventional open-heart surgery for treatment of select patients with mitral regurgitation. The findings come from updated research from the EVEREST II study presented at the American College of Cardiology’s 60th Annual Scientific Session.

Home April 08, 2011
Home
Feature | Dave Fornell

April 8, 2011 — A study from a South Korean research team found that angioplasty with a sirolimus-eluting stent was non-inferior to coronary artery bypass surgery (CABG) in patients with unprotected left main coronary artery disease.

Home April 08, 2011
Home
Technology | Radiation Dose Management

To prevent physician fatigue and back pain associated with wearing protective lead aprons in the cath lab, the ZeroGravity Radiation Protection System offers increased radiation protection without weighing down the user. Using a ceiling suspended gantry system, no weight is placed on the body of the interventionalist and it allows for smooth movement along the X, Y, Z axis.

Home April 08, 2011
Home
Heavy calcification around the Aortic bifurcation in a 3,000 year old mummy.
Feature | CT Angiography (CTA)

A U.S.-Egyptian research team has uncovered the earliest documented case of coronary atherosclerosis in a princess who died in her early 40s and lived between 1580 and 1550 B.C.

Home April 08, 2011
Home
Feature

April 8, 2011 – The U.S. Food and Drug Administration (FDA) has approved an aneurysm treatment system as a Humanitarian Use Device (HDE). NeuroVasx’s cPAX Aneurysm Treatment System can be used to treat large, giant and wide-neck cerebral aneurysms, which are typically the most difficult to treat. The HDE allows for the treatment of up to 4,000 patients per year in the United States.

Home April 08, 2011
Home
News

The U.S. Food and Drug Administration (FDA) this week released its February list of device and technology premarket approvals (PMA), product development protocols (PDP), supplement and notice decisions. To review the listing, visit: www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/PMAApprovals/ucm250089.htm

Home April 08, 2011
Home
Technology

April 8, 2011 – Spectrum Dynamics has installed the second D-SPECT (single photon emission computed tomography) system using cadmium zinc telluride (CZT) nuclear imaging detectors. The new detectors enable a new generation of high resolution, low-dose nuclear cameras.

Home April 08, 2011
Home
Feature | Dave Fornell

A transcatheter ventricular assist device performed better than intra-aortic balloon pumps (IABP), with a 21 percent reduction in major adverse events at 90 days.

Home April 08, 2011
Home
News

April 8, 2011 – At the American College of Cardiology (ACC) Annual Scientific Meeting in New Orleans, Siemens Healthcare demonstrated how users of nuclear imaging systems can use its IQ•SPECT to help reduce the length of imaging protocols.

Home April 08, 2011
Home
News

April 7, 2011 – Primary results from the RADAR Phase 2b clinical trial were announced at the American College of Cardiology (ACC) 2011 60th Annual Scientific Session. The trial looked at Regado Bioscience’s Reg1 anticoagulation system.

Home April 07, 2011
Home
Feature

April 7, 2011 – New study results have evaluated the potential inhibitory effects of certain proton pump inhibitors (PPIs) on clopidogrel (Plavix). The results showed that in healthy subjects, clopidogrel's active metabolite and inhibition of platelet function were reduced less by the co-administration of dexlansoprazole (Dexilant) or lansoprazole, rather than esomeprazole.

Home April 07, 2011
Home
News

April 7, 2011 – Data from two phase 3 trials studying a drug for high-cholesterol patients who are on lipid-lowering therapy were presented at American College of Cardiology’s (ACC) 60th Annual Scientific Session. The studies investigated mipomersen, from Genzyme, a subsidiary of sanofi-aventis, and Isis Pharmaceuticals.

Home April 07, 2011
Home
Subscribe Now